摘要
目的探讨氨氯地平联合瑞舒伐他汀钙治疗高血压合并颈动脉粥样硬化的临床疗效。方法方便选取2014年4月—2016年10月该院124例高血压合并颈动脉粥样硬化患者为研究对象,依据治疗分方法为实验组(常规治疗+氨氯地平+瑞舒伐他汀钙,62例)和对照组(常规治疗+氨氯地平,62例),对比观察两组疗效,统计不良反应。结果实验组IMT(0.98±0.07)mm、PV(0.05±0.03)cm^3,与对照组比较差异有统计学意义(tIMT=4.52,tPV=3.88,P<0.05)。结论氨氯地平联合瑞舒伐他汀钙治疗高血压合并颈动脉粥样硬化效果确切,安全可靠,值得推广使用。
Objective This paper tries to investigate the clinical efficacy of amlodipine combined with rosuvastatin calcium in the treatment of hypertension complicated with carotid atherosclerosis.Methods 124 cases of hypertension complicated with carotid atherosclerosis in this hospital from April 2014 to October 2016 were convenient selected and taken as an example.According to the treatment methods,the experimental group(routine treatment+amlodipine+rosuvastatin calcium,62 cases)and control group(conventional treatment+amlodipine,62 cases)were observed.The efficacy and adverse reactions of the two groups were observed.Results The experimental group of IMT(0.98±0.07)mm,PV(0.05±0.03)cm3,compared with the control group,the difference was statistically significant(tIMT=4.52,tPV=3.88,P<0.05).Conclusion Amlodipine combined with rosuvastatin calcium in the treatment of hypertension with carotid atherosclerosis effect is exact,safe and reliable,worthy of promotion.
作者
杜海霞
DU Hai-xia(Department of Cardiovascular Medicine,Gaogang Hospital of TCM,Taizhou,Jiangsu Province,225321 China)
出处
《中外医疗》
2017年第36期125-126,133,共3页
China & Foreign Medical Treatment
